Ravinder K. Grewal

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

Alan L. Ho, Ravinder K. Grewal, Rébecca Leboeuf et al. · New England Journal of Medicine · 2013 · 829 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +16

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

Richard J. Robbins, Qiang Wan, Ravinder K. Grewal et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 585 citations

Medicine, Nuclear Medicine, Oncology +17

Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET.

Henry Yeung, Ravinder K. Grewal, Mithat Gönen et al. · PubMed · 2003 · 377 citations

Medicine, Nuclear Medicine, Radiology +14

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study

Alison J. Moskowitz, Heiko Schöder, Joachim Yahalom et al. · The Lancet Oncology · 2015 · 266 citations

Medicine, Oncology, Pharmacology +17

Vemurafenib Redifferentiation of <i>BRAF</i> Mutant, RAI-Refractory Thyroid Cancers

Lara Dunn, Eric J. Sherman, Shrujal S. Baxi et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17